Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy

European urology oncology - Tập 5 - Trang 246-250 - 2022
Benjamin W. Fischer-Valuck1, Sagar A. Patel1, Randall J. Brenneman2, John Christodouleas3, Paul Sargos4, Eric Kim5, Aaron Weiss6, Bruce Hershatter1, Yuan J. Rao7, Joel Picus8, Bruce Roth8, Vivek Arora8, Ruben Carmona9, Melissa Reimers8, Mohamed S. Zaghloul10, Hiram Gay2, Jeff M. Michalski2, Brian C. Baumann2
1Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA
2Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, USA
3Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA
4Département de Radiothérapie, Institut Bergonié, Bordeaux, France
5Department of Urology, Washington University in St. Louis, St. Louis, MO, USA
6Department of Urology, Winship Cancer Institute of Emory University, Atlanta, GA, USA
7Department of Radiation Oncology, George Washington University, Washington, DC, USA
8Department of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA
9Department of Radiation Oncology, University of Miami, Miami, FL USA
10Radiation Oncology, Children’s Cancer Hospital and National Cancer Institute, Cairo University, Cairo, Egypt

Tài liệu tham khảo

Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590 Witjes, 2021, European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines, Eur Urol, 79, 82, 10.1016/j.eururo.2020.03.055 Rusthoven, 2016, Improved survival with prostate radiation in addition to androgen deprivation therapy for men with newly diagnosed metastatic prostate cancer, J Clin Oncol, 34, 2835, 10.1200/JCO.2016.67.4788 Parker, 2018, Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial, Lancet, 392, 2353, 10.1016/S0140-6736(18)32486-3 Seisen, 2016, Efficacy of high-intensity local treatment for metastatic urothelial carcinoma of the bladder: a propensity score-weighted analysis from the National Cancer Data Base, J Clin Oncol, 34, 3529, 10.1200/JCO.2016.66.7352 Leyh-Bannurah, 2017, Local therapy improves survival in metastatic prostate cancer, Eur Urol, 72, 118, 10.1016/j.eururo.2017.03.020 Loppenberg, 2017, The impact of local treatment on overall survival in patients with metastatic prostate cancer on diagnosis: a National Cancer Data Base analysis, Eur Urol, 72, 14, 10.1016/j.eururo.2016.04.031 Culp, 2014, Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study, Eur Urol, 65, 1058, 10.1016/j.eururo.2013.11.012 Langley, 2011, The seed and soil hypothesis revisited—the role of tumor-stroma interactions in metastasis to different organs, Int J Cancer, 128, 2527, 10.1002/ijc.26031 Hiratsuka, 2006, Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis, Nat Cell Biol, 8, 1369, 10.1038/ncb1507